L7RXH0 (L7RXH0_HUMAN) Homo sapiens (Human)
Integrin, alpha V UniProtKBInterProInteractive Modelling
1048 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P06756
It is possible new templates exist for this target since these models were created.
Available Structures
38 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Crystal structure of the complete integrin alhaVbeta3 ectodomain plus an Alpha/beta transmembrane f… |
Heteromer P05106; P06756; | 100.0 | 1×NAG; 6×NAG; 1×NAG; 2×NAG; 5×NAG; 6×CA; | |||
Re-refinement of alpha V beta 3 structure |
Heteromer P05106; P06756; | 100.0 | 1×NAG; 9×NAG; 1×NAG; 1×NAG; 7×CA; 4×NAG; 1×NA; | |||
Crystal structure of integrin alpha V beta 3 with coil-coiled tag. |
Heteromer P05106; P06756; | 100.0 | 4×NAG; 3×NAG; 1×NAG; 4×NAG; 1×NAG; 6×CA; 2×NAG; 6×SO4; 7×CL; 1×NI; | |||
CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3 |
Heteromer P05106; P06756; | 100.0 | 4×NAG; 3×NAG; 4×NAG; 6×CA; | |||
A novel adaptation of the integrin PSI domain revealed from its crystal structure |
Heteromer P05106; P06756; | 100.0 | 4×NAG; 3×NAG; 5×NAG; 6×CA; | |||
Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D |
Heteromer P05106; P06756; P12071; | 100.0 | 2×NAG; 5×NAG; 1×NAG; 1×NAG; 4×NAG; 8×MN; | |||
Integrin alphaVBeta3 in complex with EETI-II 2.5F |
Heteromer P05106; P06756; P12071; | 100.0 | 2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN; 1×CL; | |||
Integrin AlphaVBeta3 ectodomain bound to the tenth domain of Fibronectin with the IAKGDWND motif |
Heteromer P02751; P05106; P06756; | 100.0 | 2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN; | |||
CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGA… |
Heteromer P05106; P06756; | 100.0 | 4×NAG; 3×NAG; 4×NAG; 8×MN; | |||
CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+ |
Heteromer P05106; P06756; | 100.0 | 4×NAG; 3×NAG; 4×NAG; 6×MN; | |||
Integrin AlphaVBeta3 ectodomain bound to the tenth domain of Fibronectin |
Heteromer P02751; P05106; P06756; | 100.0 | 2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN; | |||
The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human alpha-V beta-3 Integrin… |
Heteromer P05106; P06756; | 99.89 | ||||
Integrin AlphaVBeta3 ectodomain bound to antagonist TDI-4161 |
Heteromer P05106; P06756; | 100.0 | 4×NAG; 1×NAG; 1×NAG; 8×NAG; 8×MN; 1×JUY; | |||
Integrin AlphaVBeta3 ectodomain bound to an antagonistic tenth domain of Fibronectin |
Heteromer P02751; P05106; P06756; | 100.0 | 4×NAG; 1×NAG; 1×NAG; 8×NAG; 8×MN; 1×NA; 2×GOL; | |||
Integrin AlphaVBeta3 ectodomain bound to Hr10 variant of the 10th domain of Fibronectin. |
Heteromer P02751; P05106; P06756; | 100.0 | 5×NAG; 1×NAG; 1×NAG; 7×NAG; 8×MN; | |||
AlphaVBeta3 integrin in complex with monoclonal antibody FAB fragment. |
Heteromer P05106; P06756; | 100.0 | 1×NAG; 1×NAG; 2×NAG; 3×NAG; 3×NAG; 5×MN; 2×NO3; | |||
Human alpha-V beta-3 Integrin (intermediate conformation) in complex with the therapeutic antibody … |
Heteromer P05106; P06756; | 99.89 | ||||
Human alpha-V beta-3 Integrin (open conformation) in complex with the therapeutic antibody LM609 |
Heteromer P05106; P06756; | 99.89 | ||||
Integrin alpha V beta 6 in complex with pro-TGF-beta |
Heteromer P01137; P06756; P18564; | 99.83 | 2×NAG; 3×NAG; 2×NAG; 5×NAG; 2×NAG; 8×CA; 4×NAG; 6×MN; | |||
Crystal structure of alpha V beta 6 with peptide |
Heteromer P06756; P10600; P18564; | 99.83 | 2×NAG; 1×NAG; 1×NAG; 2×SO4; 6×CA; 5×NAG; 1×MAN; 1×MG; | |||
Crystal structure of an atypical integrin |
Heteromer P06756; P26012; | 99.83 | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 5×CA; 3×EDO; 1×MG; 1×MES; | |||
Crystal structure of atypical integrin alphaV beta8 with proTGF-beta1 ligand peptide |
Heteromer P01137; P06756; P26012; | 99.83 | 3×NAG; 3×NAG; 1×NAG; 1×NAG; 4×NAG; 1×NAG; 10×CA; 3×NAG; 2×PEG; 2×MG; 1×GLY; | |||
Crystal structure of alpha V beta 6 |
Heteromer P06756; P18564; | 99.83 | 1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×CL; 3×SO4; 1×NI; 5×CA; 1×CAC; 1×MG; 1×NAG; | |||
Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa… |
Heteromer D1H101; P06756; P18564; Q6PMW3; | 99.83 | 2×NAG; 1×MAN; 2×NAG; 3×MAN; 3×NAG; 4×CA; | |||
Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa… |
Heteromer D1H101; P06756; P18564; Q6PMW3; | 100 | 1×MG; 2×CA; | |||
Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A. |
Heteromer A6Y878; P06756; P18564; Q6ZZ87; Q98W00; | 100 | 2×NAG; 1×MAN; 2×NAG; 3×MAN; 3×NAG; 4×CA; | |||
Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A… |
Heteromer A6Y878; P06756; P18564; Q6ZZ87; Q98W00; | 99.83 | 1×MAN; 1×NAG; 1×NAG; 2×NAG; 3×MAN; 4×NAG; 4×CA; | |||
Crystal structure of integrin alpha V beta 6 head |
Heteromer P06756; P18564; | 99.83 | 1×NAG; 2×NAG; 1×NAG; 1×NAG; 6×CA; 2×NAG; 1×SO4; 1×MES; 2×PEG; | |||
Integrin alpha-v beta-8 in complex with pro-TGF-beta1 |
Heteromer P06756; P07200; P26012; | 100 | 1×NAG; 4×NAG; 5×CA; 3×NAG; 1×MG; | |||
Integrin alpha-v beta-8 in complex with the Fabs 8B8 and 68 |
Heteromer P06756; P26012; | 100 | 6×NAG; 1×NAG; 1×NAG; 2×NAG; | |||
Integrin alpha-v beta-8 in complex with the Fabs C6D4 and 11D12v2 |
Heteromer P06756; P26012; | 100 | 1×NAG; 4×NAG; 5×CA; 3×NAG; 1×MG; | |||
Integrin alpha-v beta-8 in complex with the Fabs C6-RGD3 and 11D12v2 |
Heteromer P06756; P26012; | 100 | 1×NAG; 4×NAG; 5×CA; 3×NAG; 1×MG; | |||
avb8/L-TGF-b1/GARP |
Heteromer P06756; P26012; Q14392; | 100 | 1×NAG; 4×NAG; 3×NAG; 5×CA; 1×MG; | |||
Complex of integrin alphaV/beta8 and L-TGF-beta1 at a ratio of 1:2 |
Heteromer P01137; P06756; P26012; | 99.81 | 1×NAG; 2×NAG; 1×NAG; 5×NAG; 5×CA; 1×MN; | |||
Cryo-EM structure of Integrin AVB3 |
Heteromer P05106; P06756; | 100.0 | ||||
L-TGF-b3/avb8 |
Heteromer P06756; P10600; P26012; | 100.0 | 1×NAG; 4×NAG; 3×NAG; 5×CA; 1×MG; | |||
Integrin alpha-v beta-8 in complex with minibinder B8_BP_dsulf |
Heteromer P06756; P26012; | 99.77 | 1×NAG; 3×NAG; 5×CA; 4×NAG; 1×MG; | |||
Integrin alpha-v beta-6 in complex with minibinder B6_BP_dslf |
Heteromer P06756; P18564; | 99.77 | 1×NAG; 4×CA; 2×NAG; 3×MN; | |||
1 SWISS-MODEL model
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
3ije.1.A | monomer | 0.80 | 1×NAG; 5×CA; | 100.00 | ||